High β-III tubulin expression in triple-negative (TN) breast cancer (BC) subtype and correlation to ixabepilone response: A retrospective analysis

被引：0
|
作者：
Horak, C. E. [1 ,2 ,3 ]
Lee, F. Y. [1 ,2 ,3 ]
Xu, L. [1 ,2 ,3 ]
Galbraith, S. [1 ,2 ,3 ]
Baselga, J. [1 ,2 ,3 ]
机构：
[1] Bristol Myers Squibb Co, Pennington, NJ USA
[2] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[3] Vall Hebron Univ Hosp, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3587
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical outcome of triple-negative (TN) breast cancer (BC)
    Cabuk, D.
    Basaran, G.
    Kaya, H.
    Gulluoglu, B.
    Teomete, M.
    Dane, F.
    Yumuk, P. F.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Cerebral metastases (CM) in breast cancer (BC) with focus on "triple-negative" (TN) tumors
    Heitz, F.
    Harter, P.
    Beutel, B.
    Lueck, H. J.
    Traut, A.
    du Bois, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S100 - S100
  • [3] PTEN expression in Palestinian women with breast cancer, particularly in triple-negative subtype
    Khatib, A. A.
    Al Abed, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [4] Poor histological subtype and response to neoadjuvant treatment in triple-negative breast cancer
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (03): : 1665 - 1665
  • [5] Activity of ixabepilone and PARP inhibitors in triple-negative breast cancer (TNBC) based on gene expression.
    Horak, C. E.
    Alexe, G.
    Baselga, J.
    Vahdat, L. T.
    Valero, V.
    Xing, G.
    Mukhopadhyay, P.
    Opatt, D. M.
    Sparano, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-β Tubulin and Non-basal Subtype
    Shimada, Kazuhiro
    Ishikawa, Takashi
    Kita, Kumiko
    Narui, Kazutaka
    Sugae, Sadayoshi
    Shimizu, Daisuke
    Tanabe, Mikiko
    Sasaki, Takeshi
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    ANTICANCER RESEARCH, 2015, 35 (02) : 907 - 912
  • [7] Personalized differential expression analysis in triple-negative breast cancer
    Cai, Hao
    Chen, Liangbo
    Yang, Shuxin
    Jiang, Ronghong
    Guo, You
    He, Ming
    Luo, Yun
    Hong, Guini
    Li, Hongdong
    Song, Kai
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2024, 23 (04) : 495 - 506
  • [8] A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
    Tae-Kyung Yoo
    Jun Kang
    Awon Lee
    Byung Joo Chae
    Breast Cancer Research and Treatment, 2022, 191 : 599 - 610
  • [9] A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
    Yoo, Tae-Kyung
    Kang, Jun
    Lee, Awon
    Chae, Byung Joo
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 599 - 610
  • [10] Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
    Perez, Edith A.
    Patel, Tejal
    Moreno-Aspitia, Alvaro
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 261 - 271
12345